Lively Biotech has obtained optimistic suggestions from regulators on a protocol modification to its ongoing proof-of-concept scientific trial evaluating tasquinimod in sufferers with myelofibrosis, a...
The U.S. Meals and Drug Administration (FDA) has accepted PD-L1 IHC 22C3 pharmDx, Code SK006, as a companion diagnostic to assist establish sufferers with epithelial...
The U.S. Meals and Drug Administration (FDA) has granted orphan drug designation to zenocutuzumab-zbco for the therapy of adults with superior unresectable...
The U.S. Meals and Drug Administration (FDA) has authorized an replace to the prescribing info for Yescarta (axicabtagene ciloleucel), eradicating earlier limitations...
The investigational oral remedy KTX-1001, often known as gintemetostat, is catching curiosity as a possible therapy for a subgroup of sufferers with...
